SS Innovations International, Inc., a Nasdaq-listed pioneer in surgical robotics, has introduced a groundbreaking advancement in telesurgery: the SSI MantrAsana Tele Surgeon Console. This cutting-edge system marks a significant leap forward in remote surgical technology.
Introducing MantrAsana: The Future of Remote Surgery
MantrAsana stands as the first-ever ergonomic, portable, and fully integrated telesurgery platform designed to facilitate high-precision procedures from a distance. Engineered and manufactured entirely in India, this compact robotic system empowers expert surgeons to perform complex operations remotely, effectively bridging geographical barriers and expanding access to specialized surgical care.
Empowering Surgeons with Mobility and Precision
Dr. Sudhir Srivastava, Founder and Chairman of SS Innovations International, emphasizes that MantrAsana brings surgical expertise directly to patients, no matter their location. The console’s compact design allows surgeons to conduct telesurgeries from their own offices, eliminating the need for traditional operating theaters. Surgeons utilize lightweight, magnified 3D glasses paired with magnetic sensor-based controls to maneuver the robotic instruments with exceptional accuracy. This flexibility enables the deployment of telesurgery units in diverse settings, broadening the reach of specialized medical services.
Transforming Surgical Robotics: Insights from Medical Experts
Dr. Sudhir Rawal, Medical Director at Rajiv Gandhi Cancer Institute & Research Centre, highlights that the MantrAsana Tele Surgeon Console ushers in a new era of surgical innovation. By integrating advanced robotics with precise control mechanisms and immersive 3D visualization, the system makes remote surgery not only feasible but highly effective. Its ergonomic and space-efficient design allows installation in non-traditional environments, such as private clinics or office spaces, facilitating remote operations without occupying conventional surgical theaters.
Commercial Launch and Global Expansion Plans
MantrAsana is slated for commercial release across India by December 20, 2025, with plans for subsequent international distribution. This rollout is expected to catalyze a global transformation in how surgical expertise is delivered, particularly benefiting regions with limited access to specialized healthcare professionals.
Advancing Healthcare Accessibility Through Innovation
As the demand for telemedicine and remote healthcare solutions continues to surge-projected to grow at a CAGR of over 20% globally through 2027-the introduction of MantrAsana aligns perfectly with the evolving landscape of medical technology. By enabling surgeons to operate remotely with unparalleled precision, this innovation promises to reduce patient travel burdens, lower healthcare costs, and improve surgical outcomes worldwide.
